Cantor Fitzgerald Weighs in on Cabaletta Bio FY2025 Earnings
Cabaletta Bio, Inc. (NASDAQ:CABA – Free Report) – Analysts at Cantor Fitzgerald dropped their FY2025 earnings per share estimates for Cabaletta Bio in a research note issued to investors on Monday, May 19th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will post earnings per share of ($1.38) for the year, down from […]
